{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:45:33Z","timestamp":1787503533452,"version":"build-2736575974"},"reference-count":46,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011747","name":"grants from the Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Graves disease (GD) is one of the most common autoimmune disorders. Recent literature has shown an immune response involving several different inflammatory related proteins in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aimed to characterize the kynurenine pathway, activated during interferon-\u03b3 (IFN-\u03b3)\u2013mediated inflammation and cellular (T-helper type 1 [Th1] type) immunity, in GD patients with and without thyroid eye disease (TED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 34 biomarkers by mass spectrometry in serum samples from 100 patients with GD (36 with TED) and 100 matched healthy controls. The analytes included 10 metabolites and 3 indices from the kynurenine pathway, 6 microbiota-derived metabolites, 10 B-vitamers, and 5 serum proteins reflecting inflammation and kidney function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GD patients showed significantly elevated levels of 7 biomarkers compared with healthy controls (omega squared [\u03c92] &amp;gt; 0.06; P &amp;lt; .01). Of these 7, the 6 biomarkers with the strongest effect size were all components of the kynurenine pathway. Factor analysis showed that biomarkers related to cellular immunity and the Th1 responses (3-hydroxykynurenine, kynurenine, and quinolinic acid with the highest loading) were most strongly associated with GD. Further, a factor mainly reflecting acute phase response (C-reactive protein and serum amyloid A) showed weaker association with GD by factor analysis. There were no differences in biomarker levels between GD patients with and without TED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study supports activation of IFN-\u03b3 inflammation and Th1 cellular immunity in GD, but also a contribution of acute-phase reactants. Our finding of no difference in systemic activation of the kynurenine pathway in GD patients with and without TED implies that the local Th1 immune response in the orbit is not reflected systemically.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad004","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T23:52:01Z","timestamp":1673135521000},"page":"1290-1297","source":"Crossref","is-referenced-by-count":13,"title":["Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-9739","authenticated-orcid":false,"given":"Hans Olav","family":"Ueland","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Haukeland University Hospital , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-9690","authenticated-orcid":false,"given":"Arve","family":"Ulvik","sequence":"additional","affiliation":[{"name":"Bevital A\/S, Laboratoriebygget , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8027-8031","authenticated-orcid":false,"given":"Kristian","family":"L\u00f8v\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-2248","authenticated-orcid":false,"given":"Anette S B","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , 5021 Bergen , Norway"},{"name":"Department of Clinical Science and K.G. Jebsen Center for Autoimmune Diseases, University of Bergen , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-6611","authenticated-orcid":false,"given":"Lars Ertesv\u00e5g","family":"Breivik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , 5021 Bergen , Norway"},{"name":"Department of Clinical Science and K.G. Jebsen Center for Autoimmune Diseases, University of Bergen , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4496-615X","authenticated-orcid":false,"given":"Ann-Elin Meling","family":"Stokland","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stavanger University Hospital , 4011 Stavanger , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-4840","authenticated-orcid":false,"given":"Eyvind","family":"R\u00f8dahl","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Haukeland University Hospital , 5021 Bergen , Norway"},{"name":"Department of Clinical Medicine, University of Bergen , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0228-1550","authenticated-orcid":false,"given":"Roy Miodini","family":"Nilsen","sequence":"additional","affiliation":[{"name":"Department of Health and Functioning, Western Norway University of Applied Sciences , 5063 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-2976","authenticated-orcid":false,"given":"Eystein","family":"Husebye","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , 5021 Bergen , Norway"},{"name":"Department of Clinical Science and K.G. Jebsen Center for Autoimmune Diseases, University of Bergen , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-7689","authenticated-orcid":false,"given":"Grethe \u00c5str\u00f8m","family":"Ueland","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , 5021 Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"6","key":"2023051701095744100_dgad004-B1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"2023051701095744100_dgad004-B2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"2023051701095744100_dgad004-B3","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1210\/jc.2014-3011","article-title":"Graves\u2019 hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease","volume":"99","author":"Rapoport","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023051701095744100_dgad004-B4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves\u2019 disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"16","key":"2023051701095744100_dgad004-B5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"2023051701095744100_dgad004-B6","doi-asserted-by":"crossref","first-page":"648732","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in graves\u2019 orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2023051701095744100_dgad004-B7","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-\u03b3, indoleamine 2, 3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J"},{"key":"2023051701095744100_dgad004-B8","author":"Ueland"},{"issue":"1","key":"2023051701095744100_dgad004-B9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ajcn\/nqx012","article-title":"The PAr index, an indicator reflecting altered vitamin B-6 homeostasis, is associated with long-term risk of stroke in the general population: the Hordaland Health Study (HUSK)","volume":"107","author":"Zuo","year":"2018","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2023051701095744100_dgad004-B10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ijcard.2012.12.090","article-title":"Neopterin and kynurenine\u2013tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study","volume":"168","author":"Sulo","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023051701095744100_dgad004-B11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-4615-0135-0_46","article-title":"Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease","volume":"527","author":"Forrest","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"2023051701095744100_dgad004-B12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-0135-0_32","article-title":"Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment","volume":"527","author":"Forrest","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2023051701095744100_dgad004-B13","doi-asserted-by":"crossref","first-page":"F565","DOI":"10.1152\/ajprenal.2000.279.3.F565","article-title":"Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency","volume":"279","author":"Saito","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023051701095744100_dgad004-B14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"2023051701095744100_dgad004-B15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2023051701095744100_dgad004-B16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2014significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J Psychiatry Neurosci"},{"issue":"2","key":"2023051701095744100_dgad004-B17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-22-0247","article-title":"Novel inflammatory biomarkers in thyroid eye disease","volume":"187","author":"Ueland","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023051701095744100_dgad004-B18","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023051701095744100_dgad004-B19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with graves\u2019 ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2023051701095744100_dgad004-B20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/ijerph13121236","article-title":"Overview of cotinine cutoff values for smoking status classification","volume":"13","author":"Kim","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"2023051701095744100_dgad004-B21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.sbi.2003.10.006","article-title":"Structural biology of enzymes of the thiamin biosynthesis pathway","volume":"13","author":"Settembre","year":"2003","journal-title":"Curr Opin Struct Biol"},{"issue":"9","key":"2023051701095744100_dgad004-B22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","article-title":"Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Midttun","year":"2009","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"1","key":"2023051701095744100_dgad004-B23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ajcn\/nqz228","article-title":"Tryptophan catabolites as metabolic markers of vitamin B-6 status evaluated in cohorts of healthy adults and cardiovascular patients","volume":"111","author":"Ulvik","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2023051701095744100_dgad004-B24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3945\/ajcn.114.083196","article-title":"Evidence for increased catabolism of vitamin B-6 during systemic inflammation","volume":"100","author":"Ulvik","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"2023051701095744100_dgad004-B25","author":"Van Buuren","year":"2019"},{"key":"2023051701095744100_dgad004-B26","volume-title":"Toward Self-Regulated Learning in Vocational Education: Difficulties and Opportunities","author":"Jossberger","year":"2011"},{"issue":"4","key":"2023051701095744100_dgad004-B27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1037\/1082-989X.8.4.434","article-title":"Generalized eta and omega squared statistics: measures of effect size for some common research designs","volume":"8","author":"Olejnik","year":"2003","journal-title":"Psychol Methods"},{"issue":"56","key":"2023051701095744100_dgad004-B28","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.21105\/joss.02815","article-title":"Effectsize: estimation of effect size indices and standardized parameters","volume":"5","author":"Ben-Shachar","year":"2020","journal-title":"J. Open Source Softw"},{"issue":"5","key":"2023051701095744100_dgad004-B29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/0013164496056005002","article-title":"Practical significance: a concept whose time has come","volume":"56","author":"Kirk","year":"1996","journal-title":"Educ Psychol Meas"},{"issue":"4","key":"2023051701095744100_dgad004-B30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0029-1211240","article-title":"Increased serum neopterin levels in patients with Graves\u2019 disease","volume":"101","author":"Wagner","year":"1993","journal-title":"Exp Clin Endocrinol"},{"issue":"2","key":"2023051701095744100_dgad004-B31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr Drug Metab"},{"issue":"5","key":"2023051701095744100_dgad004-B32","first-page":"271","article-title":"Serum interferon gamma levels in autoimmune thyroid disease","volume":"13","author":"Matsubayashi","year":"1990","journal-title":"Clin Invest Med"},{"issue":"29","key":"2023051701095744100_dgad004-B33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1556\/OH.2012.29405","article-title":"Determination of serum neopterin levels in patients with autoimmune thyroid diseases","volume":"153","author":"Bal\u00e1zs","year":"2012","journal-title":"Orv Hetil"},{"issue":"6","key":"2023051701095744100_dgad004-B34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/jir.1990.10.599","article-title":"Immune activation and decreased tryptophan in patients with HIV-1 infection","volume":"10","author":"Fuchs","year":"1990","journal-title":"J Interferon Res"},{"issue":"1","key":"2023051701095744100_dgad004-B35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12020-009-9184-0","article-title":"Increased TTS abrogates IDO-mediated CD4+ T cells suppression in patients with Graves\u2019 disease","volume":"36","author":"Wang","year":"2009","journal-title":"Endocrine"},{"issue":"7","key":"2023051701095744100_dgad004-B36","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1210\/jc.2013-1273","article-title":"Plasmacytoid dendritic cells in patients with autoimmune thyroid disease","volume":"98","author":"Leskela","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2023051701095744100_dgad004-B37","doi-asserted-by":"crossref","first-page":"104024","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"2023051701095744100_dgad004-B38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.celrep.2018.09.091","article-title":"Alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase controls dietary niacin requirements for NAD+ synthesis","volume":"25","author":"Palzer","year":"2018","journal-title":"Cell Rep"},{"issue":"2","key":"2023051701095744100_dgad004-B39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1-2","key":"2023051701095744100_dgad004-B40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cccn.2003.07.022","article-title":"Serum cystatin C is sensitive to small changes in thyroid function","volume":"338","author":"Wiesli","year":"2003","journal-title":"Clin Chim Acta"},{"key":"2023051701095744100_dgad004-B41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cca.2015.10.018","article-title":"Paradoxical effects of thyroid function on glomerular filtration rate estimated from serum creatinine or standardized cystatin C in patients with Japanese Graves\u2019 disease","volume":"451","author":"Suzuki","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2023051701095744100_dgad004-B42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4158\/EP12282.OR","article-title":"Impact of thyroid function on serum cystatin C and estimated glomerular filtration rate: a cross-sectional study","volume":"19","author":"Ye","year":"2013","journal-title":"Endocr Pract"},{"issue":"5","key":"2023051701095744100_dgad004-B43","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","article-title":"Impact of thyroid dysfunction on serum cystatin C","volume":"63","author":"Fricker","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"2023051701095744100_dgad004-B44","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/147323001003800418","article-title":"Influence of thyroid hormones and transforming growth factor-\u03b21 on cystatin C concentrations","volume":"38","author":"Kotajima","year":"2010","journal-title":"J Int Med Res"},{"issue":"7","key":"2023051701095744100_dgad004-B45","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N","article-title":"Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis","volume":"43","author":"Plant","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2023051701095744100_dgad004-B46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2249.1998.00655.x","article-title":"Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases","volume":"113","author":"Bell","year":"1998","journal-title":"Clin Exp Immunol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad004\/49121881\/dgad004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/6\/1290\/50355261\/dgad004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/6\/1290\/50355261\/dgad004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T21:13:23Z","timestamp":1684271603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/6\/1290\/6972459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,1,6]]},"published-print":{"date-parts":[[2023,5,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad004","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,1,6]]}}}